Use of Rift Valley Fever Virus Expressing NanoLuc Luciferase for the Assessment of Neutralizing Antibodies and Antivirals
Crossref DOI link: https://doi.org/10.1007/978-1-0716-4338-9_2
Published Online: 2024-12-14
Published Print: 2025
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Borrego, Belén
Martinez-Sobrido, Luis
Brun, Alejandro
Nogales, Aitor
Text and Data Mining valid from 2024-12-14
Version of Record valid from 2024-12-14
Chapter History
First Online: 14 December 2024